Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Havas ECS is a healthcare communications, strategic advisory, and medical education business launched by Havas Health & You in 2019 to focus on the endocannabinoid system, cannabis science, and cannabinoid-related healthcare topics. Rather than operating as a drug developer, it provides science-based education, communications programs, and advisory services for pharmaceutical, health, wellness, legal, and consumer stakeholders. The business has emphasized clinician and stakeholder education on cannabinoid science, potential drug interactions, regulatory issues, and evidence-based decision-making. It has also collaborated on continuing education and certificate-style programming related to endocannabinoid medicine. Havas ECS appears to function as a specialized unit within the broader Havas health communications ecosystem rather than as an independent biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Havas ECS.